modified variable importance summaries to only consider drugs/compounds for which P3 was able to perform reasonably well (relative CV risk >= 0.1 for RF)
modified variable importance summaries to only consider drugs/compounds for which P3 was able to perform reasonably well (relative CV risk >= 0.1 for RF)

NCBI-Hackathons/Pharmacogenomics_Prediction_Pipeline_P3,DCGenomics/multiple_myeloma_rnaseq_drug_response_hackathon_v002,DCGenomics/Pharmacogenomics_Prediction_Pipeline_P3,DCGenomics/Pharmacogenomics_Prediction_Pipeline_P3,DCGenomics/multiple_myeloma_rnaseq_drug_response_hackathon_v002,NCBI-Hackathons/Pharmacogenomics_Prediction_Pipeline_P3,NCBI-Hackathons/Pharmacogenomics_Prediction_Pipeline_P3,DCGenomics/multiple_myeloma_rnaseq_drug_response_hackathon_v002,DCGenomics/Pharmacogenomics_Prediction_Pipeline_P3